Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3002375rdf:typepubmed:Citationlld:pubmed
pubmed-article:3002375lifeskim:mentionsumls-concept:C0008354lld:lifeskim
pubmed-article:3002375lifeskim:mentionsumls-concept:C0001455lld:lifeskim
pubmed-article:3002375lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:3002375lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:3002375lifeskim:mentionsumls-concept:C0041370lld:lifeskim
pubmed-article:3002375lifeskim:mentionsumls-concept:C0443199lld:lifeskim
pubmed-article:3002375lifeskim:mentionsumls-concept:C1948023lld:lifeskim
pubmed-article:3002375lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:3002375lifeskim:mentionsumls-concept:C0279023lld:lifeskim
pubmed-article:3002375lifeskim:mentionsumls-concept:C0033268lld:lifeskim
pubmed-article:3002375pubmed:issue3lld:pubmed
pubmed-article:3002375pubmed:dateCreated1986-2-12lld:pubmed
pubmed-article:3002375pubmed:abstractTextTetradecanoylphorbol-acetate and other tumor promoters inhibit prostaglandin E2 and isoproterenol-induced cAMP accumulation in mouse thymocytes but markedly potentiate cAMP production induced by cholera toxin. Cholera toxin is known to stimulate cAMP production by inducing ADP-ribosylation of the alpha-subunit of a guanine nucleotide-binding regulatory (G) protein, resulting in activation of the catalytic unit of adenylate cyclase. G proteins have been implicated as plasma membrane transducers for a variety of additional signals. It is possible that the growth promoting and co-mitogenic properties of tumor promoters are related to their effects on G proteins.lld:pubmed
pubmed-article:3002375pubmed:languageenglld:pubmed
pubmed-article:3002375pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3002375pubmed:citationSubsetIMlld:pubmed
pubmed-article:3002375pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3002375pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3002375pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3002375pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3002375pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3002375pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3002375pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3002375pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3002375pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3002375pubmed:statusMEDLINElld:pubmed
pubmed-article:3002375pubmed:monthDeclld:pubmed
pubmed-article:3002375pubmed:issn0006-291Xlld:pubmed
pubmed-article:3002375pubmed:authorpubmed-author:NovogrodskyAAlld:pubmed
pubmed-article:3002375pubmed:authorpubmed-author:StenzelK HKHlld:pubmed
pubmed-article:3002375pubmed:authorpubmed-author:PatykSSlld:pubmed
pubmed-article:3002375pubmed:issnTypePrintlld:pubmed
pubmed-article:3002375pubmed:day31lld:pubmed
pubmed-article:3002375pubmed:volume133lld:pubmed
pubmed-article:3002375pubmed:ownerNLMlld:pubmed
pubmed-article:3002375pubmed:authorsCompleteYlld:pubmed
pubmed-article:3002375pubmed:pagination904-10lld:pubmed
pubmed-article:3002375pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3002375pubmed:meshHeadingpubmed-meshheading:3002375-...lld:pubmed
pubmed-article:3002375pubmed:meshHeadingpubmed-meshheading:3002375-...lld:pubmed
pubmed-article:3002375pubmed:meshHeadingpubmed-meshheading:3002375-...lld:pubmed
pubmed-article:3002375pubmed:meshHeadingpubmed-meshheading:3002375-...lld:pubmed
pubmed-article:3002375pubmed:meshHeadingpubmed-meshheading:3002375-...lld:pubmed
pubmed-article:3002375pubmed:meshHeadingpubmed-meshheading:3002375-...lld:pubmed
pubmed-article:3002375pubmed:meshHeadingpubmed-meshheading:3002375-...lld:pubmed
pubmed-article:3002375pubmed:meshHeadingpubmed-meshheading:3002375-...lld:pubmed
pubmed-article:3002375pubmed:meshHeadingpubmed-meshheading:3002375-...lld:pubmed
pubmed-article:3002375pubmed:meshHeadingpubmed-meshheading:3002375-...lld:pubmed
pubmed-article:3002375pubmed:meshHeadingpubmed-meshheading:3002375-...lld:pubmed
pubmed-article:3002375pubmed:meshHeadingpubmed-meshheading:3002375-...lld:pubmed
pubmed-article:3002375pubmed:meshHeadingpubmed-meshheading:3002375-...lld:pubmed
pubmed-article:3002375pubmed:meshHeadingpubmed-meshheading:3002375-...lld:pubmed
pubmed-article:3002375pubmed:year1985lld:pubmed
pubmed-article:3002375pubmed:articleTitleDifferential effects of tumor promoters on cAMP production: inhibition of receptor-mediated and potentiation of cholera toxin-mediated stimulation.lld:pubmed
pubmed-article:3002375pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3002375pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:3002375pubmed:publicationTypeIn Vitrolld:pubmed